Interprofessional medication review shows non-significant improvement in prescribing appropriateness for older ED patients
This randomized controlled trial evaluated a structured, patient-oriented, interprofessional medication review conducted by a clinical pharmacist and geriatrician versus standard care in 151 older adults (≥65 years) admitted to the emergency department of a Copenhagen hospital. The primary outcome was the change in the Medication Appropriateness Index (MAI) score from inclusion to the 8-week follow-up.
The intervention group showed a mean improvement of 2.2 points (SD 6.6) in MAI score, compared to 1.2 points (SD 5.5) in the control group, but this difference was not statistically significant (P = 0.3). Regarding deprescribing, 295 medications (18.6%) were deprescribed overall by the 8-week follow-up, with 170 (21.3%) in the intervention group and 125 (15.9%) in the control group.
Safety and tolerability data were not reported. Key limitations were not explicitly listed in the provided evidence. The study's practice relevance is restrained; while deprescribing was identified as an important strategy, the primary outcome did not show a statistically significant benefit over standard care. The intervention did not have a notable effect on the reported secondary outcomes.